Bank Pan Indonesia Tbk vs Prodia Diagnostic Line Tbk — how do they compare? Bank Pan Indonesia Tbk trades at Rp900 (market cap 21.57T, 537.2K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp262 (market cap 470.58B, 11.72M 24h volume). The key difference: Bank Pan Indonesia Tbk is far larger — about 45.8× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (11.72M versus 537.2K). Which is the better fit depends on your goals.
| PNBN | PRDL | |
|---|---|---|
Market Cap | 21.57T | 470.58B |
Volume | 537.2K | 11.72M |
Lot | 5.37K | 117.18K |
Turnover | 485.03M | 3.09B |
Average Price | 902.89 | 263.29 |
Value | 485.03M | 3.09B |
Indicative Equilibrium Price | 905 | 272 |
Indicative Equilibrium Volume | 600 | 418 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank Pan Indonesia Tbk (the Bank) was established based on Deed No. 85 dated August 17, 1971 of notary Juliaan Nimrod Siregar gelar Mangaradja, S.H. Panin (Pan Indonesia) Bank was established by the merger of three small private banks. It was one of the first banks to be granted a foreign exchange license in 1972.
Read more on PNBN →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →